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1. Introduction 
 
I have focused my research on organic synthesis of a small novel molecule to target prostate 
cancer. This has consisted of performing multiple organic synthesis reactions as well as various 
biological assay’s. Beyond performing organic synthesis and biological assay’s, sufficient 
background research has been conducted on current forms of treatment as well as prostate 
cancer. Through the biological assay’s we have found multiple molecules to show possible 
success in targeting prostate cancer.  
 
Designing of these molecules is conducted in collaboration with Mr. Sravan K. Jonnalagadda, 
Ms. Shirisha Gurrapu, and Dr. Venkatram R Mereddy. These molecules of design consist of 
various derivatives of the current three forms of treatment. The three current forms are flutamide, 
nilutamide, and bicalutamide. These three molecules are displayed below in Figure 1. 
 
Figure 1.  
 
 
These three current forms of treatment are antiandrogen molecules that bind the androgen 
receptors (AR). This essentially causes the AR to become inactive therefore inhibiting excessive 
cell proliferation through competitive binding with Dihydrotestosterone.  
 
2. Research Methodology 
 
The organic synthesis procedures consist of the following basic steps:  
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The first step is a Bop-Cl amide coupling reaction followed by a condensation reaction between 
an amide and carboxylic acid. After these two basic mechanisms are carried out, various 
derivatives are synthesized. Approximately 15 derivatives were synthesized.  
 
The biological assay conducted on the compounds consisted of a cytotoxicity assay. LNCaP 
androgen positive prostate cancer cell line was used to carry out these toxicity evaluations on 
each compound. The cells were grown in appropriate media and plated in 24- well plates. After 
cells were plated the compound was implemented and the cells were allowed to grow for 72 
hours. After 72 hours of growth, absorbance measurements were taken. The controls used for 
normalizing absorbance measurements consisted of growth media, taxol, and DMSO. After 
absorbance measurements were taken on each compound the data was analyzed.  
 
The cytotoxicity assay was or will be conducted three times on each compound for repeatability. 
The molecules that show limited toxicity will be taken to further assays.  
 
3. Findings 
 
Through synthesis and cytoxicity tests several of the designed molecules showed limited general 
toxicity towards cells. These compounds that have shown to be successful will be repeated in 
cytoxicity tests in various dilutions. The basic functional groups and molecular shape of 
successful molecules has been noted.  
 
4. Conclusion 
 
The organic synthesis of several small molecules has shown limited general toxicity towards 
LNCaP cells. These molecules that have shown to be successful will be taken through further 
research. Continued synthesis will take place mimicking these molecules. After multiple toxicity 
assay’s have been conducted and successful results documented, these molecules will be taken 
further into proliferative binding assay tests with the presence of Dihyrotestosterone.  
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